7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Disc Medicine Inc.
(NASDAQ:IRON) 

IRON stock logo

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company is headquartered in Watertown, Massachusetts.

Founded: 2017
CEO: John Quisel  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Disc Medicine Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 03.156.39.4512.615.7518.922.06Thousand
Disc Medicine Op Cashflow Per Share ttm
202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -9.83-8.42-7.02-5.62-4.21-2.81-1.40
Disc Medicine Free Cashflow Per Share ttm
202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -9.83-8.42-7.02-5.62-4.21-2.81-1.40
Disc Medicine Cash Per Share ttm
202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 03.366.7210.0813.4416.820.1623.52
Disc Medicine (GAAP) P/E ratio ttm
202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -25-21.42-17.85-14.28-10.71-7.14-3.570
Disc Medicine P/B ratio ttm
202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.182.353.534.75.887.058.23
No extra charts and metrics for this ticker.